Iambic Therapeutics IAM
NASDAQ IAM
$14.27 -0.51 (-3.42%)
As of: Nov 11, 2026 · 9:38 AM EST

Iambic Therapeutics (IAM) Invested Capital (2024 - 2026)

Analysis

Iambic Therapeutics (IAM) Invested Capital (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Iambic Therapeutics 63.00 Mn -144.88 Mn - -231.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -231.84 Mn
Dec 31, 2025 -185.89 Mn
Dec 31, 2024 -111.59 Mn
API Access

Iambic Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=IAM&period=max&api_key=YOUR_API_KEY